Maria Victoria Olmedo-Gaya1, Francisco J Manzano-Moreno2,3, Rafael Galvez-Mateos4, Maria Paloma González-Rodriguez1, Cristina Talero-Sevilla1, Manuel Vallecillo-Capilla1. 1. Department of Stomatology, School of Dentistry, University of Granada, Colegio Máximo s/n, Campus Universitario de Cartuja, 18071, Granada, Spain. 2. Department of Stomatology, School of Dentistry, University of Granada, Colegio Máximo s/n, Campus Universitario de Cartuja, 18071, Granada, Spain. fjmanza@ugr.es. 3. Biomedical Research Group (BIO277), Junta de Andalucía, Granada, Spain. fjmanza@ugr.es. 4. Department of Anesthesia, Virgen de las Nieves University Hospital, Granada, Spain.
Abstract
OBJECTIVES: The aim of this randomized controlled clinical trial was to evaluate the efficacy and safety of pregabalin administered pre- and postoperatively in patients with pain and swelling due to the surgical removal of impacted lower third molars. MATERIALS AND METHODS: The final study sample comprised 60 volunteers (23 males and 37 females). Group 1 (n = 30) received 75 mg oral pregabalin 1 h before surgery and 1 h after surgery. Group 2 (n = 30) served as a control group and received no pregabalin. Both groups were administered with 650 mg paracetamol every 8 h for 2 days. Postoperative pain intensity and swelling were measured using a visual analog scale (VAS); pain relief experienced was reported using a four-point verbal rating scale (VRS); the rescue medication requirement, adverse effects, and global impression of the medication were also recorded. RESULTS: No significant difference in pain intensity (VAS) was observed between the groups. However, fewer rescue medication tablets were needed by pregabalin-treated patients than by controls (p = 0.021). The frequency and intensity of adverse effects were significantly higher in pregabalin-treated patients (p < 0.001), although no serious adverse events occurred. No significant difference in the degree of swelling was observed in any measurement except that from mandibular angle to lip junction, which showed lesser inflammation in the pregabalin group at 24 h post-surgery (p = 0.011). The global opinion on the medication received was more positive in the pregabalin group (p = 0.042). CONCLUSIONS: The administration of pregabalin reduces the requirement for rescue medication after third molar surgery and results in a more constant pain level, with fewer peaks of pain intensity. CLINICAL RELEVANCE: These findings suggest that pregabalin may be useful to control acute postoperative pain. Adverse effects are known to be reduced at the low pregabalin dose used in our study.
RCT Entities:
OBJECTIVES: The aim of this randomized controlled clinical trial was to evaluate the efficacy and safety of pregabalin administered pre- and postoperatively in patients with pain and swelling due to the surgical removal of impacted lower third molars. MATERIALS AND METHODS: The final study sample comprised 60 volunteers (23 males and 37 females). Group 1 (n = 30) received 75 mg oral pregabalin 1 h before surgery and 1 h after surgery. Group 2 (n = 30) served as a control group and received no pregabalin. Both groups were administered with 650 mg paracetamol every 8 h for 2 days. Postoperative pain intensity and swelling were measured using a visual analog scale (VAS); pain relief experienced was reported using a four-point verbal rating scale (VRS); the rescue medication requirement, adverse effects, and global impression of the medication were also recorded. RESULTS: No significant difference in pain intensity (VAS) was observed between the groups. However, fewer rescue medication tablets were needed by pregabalin-treated patients than by controls (p = 0.021). The frequency and intensity of adverse effects were significantly higher in pregabalin-treated patients (p < 0.001), although no serious adverse events occurred. No significant difference in the degree of swelling was observed in any measurement except that from mandibular angle to lip junction, which showed lesser inflammation in the pregabalin group at 24 h post-surgery (p = 0.011). The global opinion on the medication received was more positive in the pregabalin group (p = 0.042). CONCLUSIONS: The administration of pregabalin reduces the requirement for rescue medication after third molar surgery and results in a more constant pain level, with fewer peaks of pain intensity. CLINICAL RELEVANCE: These findings suggest that pregabalin may be useful to control acute postoperative pain. Adverse effects are known to be reduced at the low pregabalin dose used in our study.
Entities:
Keywords:
Acute pain; Postoperative pain; Pregabalin; Surgery; Third molar
Authors: Brett R Stacey; Robert H Dworkin; Kevin Murphy; Uma Sharma; Birol Emir; Teresa Griesing Journal: Pain Med Date: 2008-03-11 Impact factor: 3.750
Authors: Solomon Tesfaye; Stefan Wilhelm; Alberto Lledo; Alexander Schacht; Thomas Tölle; Didier Bouhassira; Giorgio Cruccu; Vladimir Skljarevski; Rainer Freynhagen Journal: Pain Date: 2013-05-31 Impact factor: 6.961
Authors: Klaus Schaffler; Laurent B Nicolas; Andreas Borta; Tobias Brand; Peter Reitmeir; Robert Roebling; Joachim Scholpp Journal: Br J Clin Pharmacol Date: 2017-02-27 Impact factor: 4.335
Authors: Sara Liébana-Hermoso; Francisco Javier Manzano-Moreno; Manuel Francisco Vallecillo-Capilla; Maria Victoria Olmedo-Gaya Journal: Clin Oral Investig Date: 2017-11-03 Impact factor: 3.573
Authors: Maria Victoria Olmedo-Gaya; Francisco Javier Manzano-Moreno; Jose Luis Muñoz-López; Manuel Francisco Vallecillo-Capilla; Candela Reyes-Botella Journal: Clin Oral Investig Date: 2018-02-15 Impact factor: 3.573
Authors: Alireza Rahat Dahmardeh; Amir Moosavi; Seyed Muhammad Nasir-Al-Din Tabatabaei; Jamshid Ordoni Avval; Mohammad Sistanizad Journal: Iran J Pharm Res Date: 2018 Impact factor: 1.696